enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA-approved nasal spray for severe depression can lead to ...

   www.aol.com/fda-approved-nasal-spray-severe...

   The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

3. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   Amisulpride (Solian) – approved in low doses as a monotherapy for persistent depression and major depressive disorder [10] Levosulpiride – approved in low doses for major depressive disorder [11] Lumateperone (Caplyta) – approved as a monotherapy for bipolar depression; Lurasidone (Latuda) – approved as a monotherapy for bipolar depression

4. FDA approves Johnson & Johnson’s ketamine-derived ... - AOL

   www.aol.com/finance/fda-approves-johnson-johnson...

   The nasal spray was first approved by the FDA in 2019 as a supplemental treatment, along with an oral medication, for the approximately one-third of people with MDD who struggle with treatment ...

5. Nose spray to treat depression? FDA approves first-of-its ...

   www.aol.com/nose-spray-treat-depression-fda...

   NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...

6. List of psychotropic medications - Wikipedia

   en.wikipedia.org/wiki/List_of_psychotropic...

   Vistaril (hydroxyzine) – an antihistamine for the treatment of itches and irritations, an antiemetic, as a weak analgesic, an opioid potentiator, and as an anxiolytic; Vyvanse (lisdexamfetamine) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder; Vyvanse is converted into Dexedrine in vivo

7. Ketamine-assisted psychotherapy - Wikipedia

   en.wikipedia.org/wiki/Ketamine-assisted...

   Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]